Equities

Exicure Inc

Exicure Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)10.64
  • Today's Change-0.55 / -4.92%
  • Shares traded768.77k
  • 1 Year change+330.77%
  • Beta1.6648
Data delayed at least 15 minutes, as of Nov 21 2024 18:38 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Share price forecast

The one analyst offering a 12 month price target expects Exicure Inc share price to fall to 2.00 in the next year from the last price of 11.19.
High-82.1%2.00
Med-82.1%2.00
Low-82.1%2.00

Earnings history & estimates in USD

On Mar 27, 2023, earnings of 20.50 per share.
Average growth rate+37.21%
Exicure Inc reported annual 2022 losses of -2.80 per share on Mar 27, 2023.
Average growth rate-1.45%
More ▼

Revenue history & estimates in USD

Exicure, Inc. had revenues for the full year 2022 of 28.83m. Last year the company did not report any revenues.
Average growth rate+1,090.09%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.